Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-15-069481

Chief Financial Officer sold 3,000 shares at $11.33 ($33,990)

  • Chief Financial Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Knudson Susan A. Chief Financial Officer 2015-09-01 Option exercise +3,000 $1.22 $3,660 3,492 D
Knudson Susan A. Chief Financial Officer 2015-09-01 Sale −3,000 $11.33 $33,990 492 D
Derivatives
Knudson Susan A. Chief Financial Officer 2015-09-01 Option exercise · Stock Option (Right to Buy) −3,000 30,718 D
Open-market sales · 3,000 sh · avg $11.33 · $33,990
Loading xslF345X03/doc4.xml…